Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-16-005062
Filing Date
2016-03-14
Accepted
2016-03-14 16:33:53
Documents
73
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K mbvx10k_dec312015.htm 10-K 2381900
2 FORM OF AMENDMENT AGREEMENT ex10-54.htm EX-10.54 22346
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-1.htm EX-23.1 3226
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES ex31-1.htm EX-31.1 17938
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES ex31-2.htm EX-31.2 18334
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ex32-1.htm EX-32.1 7750
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ex32-2.htm EX-32.2 7880
  Complete submission text file 0001415889-16-005062.txt   6036693

Data Files

Seq Description Document Type Size
8 mbvx-20151231.xml EX-101.INS 770840
9 mbvx-20151231.xsd EX-101.SCH 68068
10 mbvx-20151231_cal.xml EX-101.CAL 65380
11 mbvx-20151231_def.xml EX-101.DEF 204287
12 mbvx-20151231_lab.xml EX-101.LAB 422414
13 mbvx-20151231_pre.xml EX-101.PRE 310745
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

EIN.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31265 | Film No.: 161504245
SIC: 2834 Pharmaceutical Preparations